Calendar 4D Molecular Therapeutics, Inc.

Equities

FDMT

US35104E1001

Market Closed - Nasdaq 04:00:00 2024-03-28 pm EDT 5-day change 1st Jan Change
31.86 USD -11.18% Intraday chart for 4D Molecular Therapeutics, Inc. -5.74% +57.26%

Chart calendar 4D Molecular Therapeutics, Inc.

7d669f77c3998d5eabf3.s8lFTQox6oK4HD__Ef0ipxo6v0wsMQLvpUQcdqHz3p4.-J8MK05-2OjuWwmbZrlIxkpO8zRZf2u34i9UIvuQktnZmgYCP3imyN9KCw~c2260d66ae0fab1551a3af72ed6bdc6f

Upcoming events on 4D Molecular Therapeutics, Inc.

2024-05-08 Q1 2024 Earnings Release (Projected)
2024-06-04 European Cystic Fibrosis Conference
2024-08-07 Q2 2024 Earnings Release (Projected)
2024-11-05 Q3 2024 Earnings Release (Projected)
2025-03-30 Q4 2024 Earnings Release (Projected)

Past events on 4D Molecular Therapeutics, Inc.

2024-03-13 08:30 am Barclays Global Healthcare Conference
2024-03-12 11:20 am Leerink Partners Global Biopharma Conference
2024-02-29 04:05 pm Q4 2023 Earnings Release
2024-02-05 08:00 am Phase 2 PRISM Clinical Trial Update Call
2024-02-03 03:30 pm Angiogenesis Exudation and Degeneration Conference
2023-11-28 01:45 pm Evercore ISI HealthCONx Conference
2023-11-09 04:19 pm Q3 2023 Earnings Release
2023-11-03 05:30 pm North American Cystic Fibrosis Conference
2023-11-02 06:30 pm North American Cystic Fibrosis Conference
2023-11-01 04:30 pm AEROW Phase 1/2 Clinical Trail Call
2023-10-10 Cell & Gene Meeting on the Mesa Conference
2023-10-02 02:30 pm Chardan Genetic Medicines Conference
2023-09-28 12:40 pm Cantor Global Healthcare Conference
2023-09-26 08:30 am Jefferies Cell & Genetic Medicine Summit
2023-09-11 12:00 pm H.C. Wainwright Global Investment Conference
2023-08-09 04:05 pm Q2 2023 Earnings Release
2023-07-28 American Society of Retina Meeting
2023-06-12 05:00 pm Goldman Sachs Global Healthcare Conference
2023-06-09 10:00 am Jefferies Global Healthcare Conference
2023-06-08 11:00 am European Cystic Fibrosis Society Meeting

Annual results

Fiscal PeriodDecember 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
13,6
15,2
-10.5%
18,0
18,8
-4.21%
3,13
4,41
-29.03%
20,7
22,6
-8.38%

6,35

EBITDA
Million USD
Released
Forecast
Spread
-55,2
-52,1
-5.91%
-69,8
-71,9
2.85%
-108
-108
0.24%
-109
-109
0.73%

-164

EBIT
Million USD
Released
Forecast
Spread
-56,7
-53,2
-6.44%
-71,3
-73,4
2.77%
-110
-110
-0.31%
-113
-111
-1.26%

-152

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
-107
-107
-0.64%
-101
-100
-0.51%

-152

Net income
Million USD
Released
Forecast
Spread
-56,7
-50,0
-13.48%
-71,3
-71,7
0.47%
-107
-104
-2.95%
-101
-98,0
-2.9%

-156

EPS
USD
Released
Forecast
Spread
-8,82
-1,89
-366.67%
-2,57
-2,55
-0.78%
-3,32
-3,20
-3.81%
-2,58
-2,54
-1.51%

-3,13

Announcement Date25/03/2128/03/2215/03/2329/02/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales
Million USD
Released
Forecast
Spread
0,09
1,35
-93.19%
1,22
0,76
60.75%
0,16
1,14
-85.81%
0,50
1,17
-57.2%
1,25
3,76
-66.81%
0,30
1,29
-76.81%
0,24
1,02
-76.52%
20,2
9,22
119.15%
-0,02
2,40
-100.79%

1,18


1,15


1,21


1,14


0,50

EBITDA
Million USD
Released
Forecast
Spread
-24,4
-26,1
6.56%



-28,0
-28,0
-0.03%






-29,1
-30,7
5.14%
























EBIT
Million USD
Released
Forecast
Spread
-24,8
-26,8
7.57%
-26,4
-27,1
2.47%
-28,4
-29,4
3.23%
-26,5
-31,1
14.79%
-28,7
-28,4
-1.21%
-30,1
-31,5
4.36%
-32,1
-31,5
-2.11%
-14,0
-28,7
51.28%
-36,7
-35,8
-2.43%

-37,8


-40,0


-42,1


-44,7


-46,0

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread






-28,1
-25,7
-9.35%
-25,7
-28,3
9.16%
-27,4
-26,7
-2.57%
-28,7
-29,4
2.28%
-29,6
-30,0
1.41%
-10,3
-29,4
65.1%
-32,3
-31,9
-1.07%

-35,8


-37,3


-38,8


-40,4




Net income
Million USD
Released
Forecast
Spread
-25,1
-25,4
1.33%
-26,3
-24,9
-5.89%
-28,1
-25,3
-11.03%
-25,7
-27,6
6.77%
-27,4
-24,3
-12.76%
-28,7
-28,1
-2.07%
-29,6
-29,4
-0.74%
-10,3
-26,3
60.98%
-32,3
-28,9
-11.6%

-34,9


-37,0


-39,8


-46,0




EPS
USD
Released
Forecast
Spread
-0,85
-0,79
-7.59%
-0,82
-0,73
-13.1%
-0,87
-0,78
-12.02%
-0,79
-0,85
6.69%
-0,84
-0,75
-12.75%
-0,88
-0,88
-0.57%
-0,77
-0,76
-1.58%
-0,24
-0,61
60.76%
-0,77
-0,71
-8.71%

-0,71


-0,73


-0,77


-0,85




Announcement Date28/03/2212/05/2211/08/2208/11/2215/03/2310/05/2309/08/2309/11/2329/02/24-----

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise